Matsuyama Shogo, Teraoka Rie, Mori Hiroshi, Tomiyama Takami
Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe, Japan.
Neuroreport. 2007 Jul 2;18(10):1083-7. doi: 10.1097/WNR.0b013e3281e72b18.
Soluble amyloid beta peptide (Abeta) is believed to cause synaptic dysfunction in the early stages of Alzheimer's disease. Here, we examined in-vivo synaptic functions in the hippocampus in two lines of transgenic mice expressing different amounts of human wild-type amyloid precursor protein (APP). Compared with nontransgenic littermates, one transgenic line with higher APP expression displayed potent inhibition of paired-pulse facilitation and long-term potentiation in the absence of amyloid deposition, whereas the line with lower APP expression exhibited moderate inhibition of paired-pulse facilitation and long-term potentiation. Soluble Abeta1-42 levels in their brains nearly paralleled APP levels. The observed inverse correlation between APP expression and synaptic plasticity appears to support the current hypothesis regarding the pathogenic roles of soluble Abeta.
可溶性淀粉样β肽(Aβ)被认为在阿尔茨海默病的早期阶段导致突触功能障碍。在此,我们检测了两条表达不同量人类野生型淀粉样前体蛋白(APP)的转基因小鼠海马体中的体内突触功能。与非转基因同窝小鼠相比,一个APP表达较高的转基因品系在没有淀粉样沉积的情况下对双脉冲易化和长时程增强表现出强烈抑制,而APP表达较低的品系对双脉冲易化和长时程增强表现出中度抑制。它们大脑中的可溶性Aβ1-42水平几乎与APP水平平行。观察到的APP表达与突触可塑性之间的负相关似乎支持了关于可溶性Aβ致病作用的当前假说。